Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
2022年11月23日 - 01:45AM
ビジネスワイヤ(英語)
- AI Showcase Theater Presentation: “Enabling Lung Cancer
Screening with iBiopsy® AI-based Software as Medical Device”
- Scientific Presentation: ”Development of an AI/ML Tech Based
Pulmonary Nodule Malignancy Prediction Model: Application to
Indeterminate Pulmonary Nodules and Early-Stage Cancers”
- Virtual Poster Presentation: “Discordance rates on primary
tumor assessment between Blinded Independent Central Review (BICR)
readers in advanced or metastatic esophageal cancer applying RECIST
1.1 criteria”
- Median’s teams will be at booth #4849 AI showcase, to present
the latest developments on iBiopsy® as well as its imaging CRO
offering.
Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announced today that
the Company will be speaking and presenting at the world’s largest
medical imaging conference, the 2022 Radiological Society of North
America (RSNA) Annual Meeting and Scientific Assembly, being held
in Chicago, IL, USA, Nov. 27 – Dec. 1.
The Company will give an industry presentation and two
scientific presentations. Details of the sessions include:
Industry presentation: “Enabling lung cancer screening
with iBiopsy® AI-based software as medical device”
Session: AI Showcase Theater Date: November
27, 2022 Time: 11:30 am – 11:45 am CST Place: South Hall Level 3,
AI showcase theater
Virtual Poster Presentation: “Discordance rates on
primary tumor assessment between Blinded Independent Central Review
(BICR) readers in advanced or metastatic esophageal cancer applying
RECIST 1.1 criteria”
Session Number: W5B-SPGI Date: November 30,
2022 Time: 12:45 pm - 1:15 pm CST Place: East Level 3, Learning
Center – GI DPS
Scientific Presentation: ”Development of an AI/ML Tech
Based Pulmonary Nodule Malignancy Prediction Model: Application to
Indeterminate Pulmonary Nodules and Early-Stage Cancers”
Session Number: W7-SSIN06-1 Date: November
30, 2022 Time: 3.00 pm - 4.00 pm CST Place: South Level 4, S404
Median’s teams will be available at booth #4849, Level 3 South
Hall (AI showcase) for the duration of the industry exhibition (Nov
27- 30).
About Median Technologies: Median Technologies provides
innovative imaging solutions and services to advance healthcare for
everyone. We harness the power of medical images by using the most
advanced Artificial Intelligence technologies, to increase the
accuracy of diagnosis and treatment of many cancers and other
metabolic diseases at their earliest stages and provide insights
into novel therapies for patients. Our iCRO solutions for medical
image analysis and management in oncology trials and iBiopsy®, our
AI-powered software as medical device help biopharmaceutical
companies and clinicians to bring new treatments and diagnose
patients earlier and more accurately. This is how we are helping to
create a healthier world.
Founded in 2002, based in Sophia-Antipolis, France, with a
subsidiary in the US and another one in Shanghai, Median has
received the label “Innovative company” by the BPI and is listed on
Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median
is eligible for the French SME equity savings plan scheme
(PEA-PME), is part of the Enternext® PEA-PME 150 index and has been
awarded the Euronext European Rising Tech label. For more
information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221122005416/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com
Press - ALIZE RP Caroline Carmagnol +33 6 64 18 99 59
median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49 24
ggasparetto@actifin.fr
Median Technologies (EU:ALMDT)
過去 株価チャート
から 2 2024 まで 3 2024
Median Technologies (EU:ALMDT)
過去 株価チャート
から 3 2023 まで 3 2024